It was initially identified as a potential CSC target by the observations that CD47 expression is elevated on AML LSC compared with normal bone marrow stem cells and high CD47 expression at diagnosis predicts worse overall survival (OS) in AML patients.14 Here, CD47 is linked to acute myeloid leukemia.